The Strategy Research of Pharmaceutical Enterprises-Taking Pfizer as an Example

DOI

10.2991/978-94-6463-098-5_28How to use a DOI?

Keywords

Pharmaceutical industry; Pfizer; Blockbuster drugs; Covid-19; Mergers & Acquisitions

Abstract

The entire pharmaceutical industry has experienced high-speed growth in the past 30 years using different strategies. This paper will evaluate different kinds of strategies run by pharmaceutical enterprises, taking Pfizer as an example, and see how effective they are. The issues and obstacles of the strategies will also be addressed. In this paper, we can see that Pfizer keeps benefitting from its strategies such as blockbuster drugs, M&As and restruction of employees in the last two decades, which helps it lead the pharmaceutical industry. In the future, Pfizer will continue researching blockbuster drugs and conducting M&As supported by the considerable Covid-19 vaccine income to remain the seat in the industry.

Copyright

© 2023 The Author(s)

Open Access

Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

TY  - CONF
AU  - Siyuan Yang
PY  - 2022
DA  - 2022/12/27
TI  - The Strategy Research of Pharmaceutical Enterprises-Taking Pfizer as an Example
BT  - Proceedings of the 2022 4th International Conference on Economic Management and Cultural Industry (ICEMCI 2022)
PB  - Atlantis Press
SP  - 228
EP  - 235
SN  - 2352-5428
UR  - https://doi.org/10.2991/978-94-6463-098-5_28
DO  - 10.2991/978-94-6463-098-5_28
ID  - Yang2022
ER  -